| Literature DB >> 30453505 |
Miguel D Ferrer1,2,3, Xavier Capó4,5,6, Miquel Martorell7,8,9, Carla Busquets-Cortés10,11,12, Cristina Bouzas13,14, Sandra Carreres15,16, David Mateos17,18, Antoni Sureda19,20,21, Josep A Tur22,23, Antoni Pons24,25.
Abstract
A chronic inflammatory state is a major characteristic of the aging process, and physical activity is proposed as a key component for healthy aging. Our aim was to evaluate the body composition, hypertension, lipid profile, and inflammatory status of older adults, and these factors' association with physical activity. A total of 116 elderly volunteers were categorized into terciles of quantitative metabolic equivalents of task (MET). Subjects in the first and third terciles were defined as sedentary and active subjects, respectively. Anthropometric and biochemical parameters, hemograms, and inflammatory markers were measured in plasma or peripheral mononuclear blood cells (PBMCs). The active groups exercised more than their sedentary counterparts. The practice of physical activity was accompanied by lower weight, fat mass, body mass index, and diastolic blood pressure when compared to a more sedentary life-style. Physical activity also lowered the haematocrit and total leukocyte, neutrophil, and lymphocyte counts. The practice of exercise induced a decrease in the IL-6 circulating levels and the TLR2 protein levels in PBMCs, while the expression of the anti-inflammatory IL-10 was activated in active subjects. The regular practice of physical activity exerts beneficial effects on body composition and the anti-inflammatory status of old people.Entities:
Keywords: immunity; inflammation; metabolism; physical activity
Mesh:
Substances:
Year: 2018 PMID: 30453505 PMCID: PMC6266855 DOI: 10.3390/nu10111780
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Primers and conditions used in the PCRs.
| Gene | Primer | Conditions | ||
|---|---|---|---|---|
| 18S | Fw: | 5′-ATG TGA AGT CAC TGT GCC AG-3′ | 95 °C | 10 s |
| Rv: | 5′-GTG TAA TCC GTC TCC ACA GA-3′ | |||
| IL-1ra | Fw: | 5′-GAA GAT GTG CCT GTC CTG TGT-3′ | 95 °C | 10 s |
| Rv: | 5′-CGC TCA GGT CAG TGA TGT TAA-3′ | |||
| IL10 | Fw: | 5′-AGA ACC TGA AGA CCC TCA GGC-3′ | 95 °C | 10 s |
| Rv: | 5′-CCA CGG CCT TGC TCT TGT T-3′ | |||
| IL1β | Fw: | 5′-GGA CAG GAT ATG GAG CAA CA-3′ | 95 °C | 10 s |
| Rv: | 5′-GGC AGA CTC AAA TTC CAG CT-3′ | |||
| NFκB | Fw: | 5′-AAA CAC TGT GAG GAT GGG ATC TG-3′ | 95 °C | 10 s |
| Rv: | 5′-CGA AGC CGA CCA CCA TGT-3′ | |||
| TLR4 | Fw: | 5′-GGT CAC CTT TTC TTG ATT CCA-3′ | 95 °C | 10 s |
| Rv: | 5′-TCA GAG GTC CAT CAA ACA TCA C-3′ | |||
| TNFα | Fw: | 5′-CCC AGG CAG TCA GAT CAT CTT CTC GGA A-3′ | 94 °C | 10 s |
| Rv: | 5′-CTG GTT ATC TCT CAG CTC CAC GCC ATT-3′ | |||
| IL6 | Fw: | 5′-ACC TGA ACC TTC CAA AGA TGG C-3′ | 95 °C | 10 s |
| Rv: | 5′-TCA CCA GGC AAG TCT CCT CAT TG-3′ | |||
The relative quantification was performed by standard calculations considering 2(−ΔΔ. mRNA levels of sedentary males were arbitrarily referred to as 1. The expression of the target gene was normalized with respect to ribosomal 18S.
Anthropometric characteristics of the participants.
| Sedentary | Active | ANOVA | ||||
|---|---|---|---|---|---|---|
| Sex | Exercise | SxE | ||||
| Age (years) | Male | 64.6 ± 1.1 | 62.5 ± 0.9 | 0.000 | 0.339 | 0.281 |
| Female | 67.3 ± 1.1 | 67.4 ± 1.0 * | ||||
| Physical activity (MET-hours/week) | Male | 40.4 ± 4.4 | 141 ± 9 # | 0.602 | 0.000 | 0.071 |
| Female | 48.4 ± 3.3 | 126 ± 6 # | ||||
| Weight (kg) | Male | 86.1 ± 1.9 | 78.2 ± 2.0 # | 0.000 | 0.000 | 0.875 |
| Female | 69.3 ± 2.2 * | 62.0 ± 1.7 * | ||||
| Height (cm) | Male | 170 ± 1 | 171 ± 1 | 0.000 | 0.808 | 0.624 |
| Female | 157 ± 1 * | 156 ± 1 * | ||||
| Fat-free mass (kg) | Male | 61.1 ± 1.1 | 58.8 ± 1.4 | 0.000 | 0.142 | 0.531 |
| Female | 41.8 ± 0.9 * | 40.9 ± 0.6 * | ||||
| Fat mass (kg) | Male | 25.0 ± 1.1 | 19.4 ± 0.9 # | 0.090 | 0.000 | 0.765 |
| Female | 27.5 ± 1.6 | 21.2 ± 1.2 # | ||||
| Body Mass Index (kg/m2) | Male | 29.6 ± 0.6 | 26.8 ± 0.5 # | 0.038 | 0.000 | 0.874 |
| Female | 28.1 ± 0.8 | 25.5 ± 0.7 # | ||||
| Systolic blood pressure (mm Hg) | Male | 141 ± 3 | 138 ± 4 | 0.312 | 0.312 | 0.796 |
| Female | 138 ± 4 | 133 ± 3 | ||||
| Diastolic blood pressure (mm Hg) | Male | 84.8 ± 1.4 | 81.2 ± 1.8 | 0.099 | 0.039 | 0.883 |
| Female | 82.0 ± 2.2 | 77.8 ± 1.8 | ||||
Mean ± SEM. Statistical analysis: two-way ANOVA, p < 0.05. (S) effect of sex, (E) effect of exercise, and (SxE) interaction between the two factors. (*) significant differences between sexes; (#) significant differences between sedentary and active groups.
Biochemical parameters and hemogram of the participants.
| Sedentary | Active | ANOVA | ||||
|---|---|---|---|---|---|---|
| Sex | Exercise | SxE | ||||
| Glucose (mg/dL) | Male | 100 ± 2 | 98.8 ± 2.8 | 0.636 | 0.153 | 0.217 |
| Female | 105 ± 12 | 87.8 ± 1.8 | ||||
| Triglycerides (mg/dL) | Male | 111 ± 7 | 100 ± 6 | 0.360 | 0.564 | 0.289 |
| Female | 97.2 ± 6.3 | 100 ± 6 | ||||
| Total cholesterol (mg/dL) | Male | 197 ± 5 | 199 + 5 | 0.016 | 0.919 | 0.732 |
| Female | 214 ± 7 | 211 ± 6 | ||||
| HDL (mg/dL) | Male | 44.7 ± 1.6 | 51.6 ± 2.2 | 0.000 | 0.011 | 0.520 |
| Female | 57.2 ± 2.0 * | 61.3 ± 2.5 * | ||||
| LDL (mg/dL) | Male | 130 ± 5 | 127 ± 5 | 0.360 | 0.317 | 0.676 |
| Female | 137 ± 6 | 130 ± 5 | ||||
| VLDL (mg/dL) | Male | 22.3 ± 1.4 | 19.9 ± 1.3 | 0.364 | 0.532 | 0.285 |
| Female | 19.5 ± 1.3 | 20.1 ± 1.8 | ||||
| Urea (mg/dL) | Male | 36.3 ± 1.5 | 36.2 ± 1.7 | 0.754 | 0.883 | 0.909 |
| Female | 36.0 ± 1.5 | 35.6 ± 1.2 | ||||
| Uric acid (mg/dL) | Male | 6.25 ± 0.21 | 6.03 ± 0.18 | 0.000 | 0.087 | 0.515 |
| Female | 5.04 ± 0.22 * | 4.56 ± 0.20 * | ||||
| Creatinine (mg/dL) | Male | 0.829 ± 0.018 | 0.841 ± 0.016 | 0.000 | 0.978 | 0.460 |
| Female | 0.728 ± 0.013 * | 0.716 ± 0.018 * | ||||
| Red blood cells (106/mm3) | Male | 5.03 ± 0.08 | 4.90 ± 0.07 | 0.000 | 0.103 | 0.860 |
| Female | 4.62 ± 0.06 * | 4.52 ± 0.08 * | ||||
| Haemoglobin (g/dL) | Male | 15.5 ± 0.2 | 15.3 ± 0.2 | 0.000 | 0.056 | 0.798 |
| Female | 14.2 ± 0.2 * | 13.8 ± 0.1 * | ||||
| Haematocrit (%) | Male | 46.0 ± 0.5 | 45.0 ± 0.6 | 0.000 | 0.048 | 0.971 |
| Female | 42.1 ± 0.5 * | 41.1 ± 0.4 * | ||||
| Mean corpuscular volume (fL) | Male | 91.7 ± 0.9 | 91.9 ± 0.6 | 0.480 | 0.916 | 0.857 |
| Female | 91.3 ± 0.7 | 91.2 ± 0.9 | ||||
| Platelets (103/mm3) | Male | 222 ± 10 | 214 ± 8 | 0.018 | 0.195 | 0.743 |
| Female | 246 ± 9 | 232 ± 8 | ||||
| Leucocytes (103/mm3) | Male | 6.39 ± 0.29 | 5.85 ± 0.21 | 0.423 | 0.002 | 0.244 |
| Female | 6.49 ± 0.32 | 5.33 ± 0.21 # | ||||
| Neutrophils (103/mm3) | Male | 3.43 ± 0.21 | 3.15 ± 0.18 | 0.074 | 0.006 | 0.185 |
| Female | 3.35 ± 0.22 | 2.56 ± 0.13 # | ||||
| Lymphocytes (103/mm3) | Male | 2.20 ± 0.13 | 1.94 ± 0.09 | 0.084 | 0.039 | 0.997 |
| Female | 2.41 ± 0.14 | 2.15 ± 0.12 | ||||
| Monocytes (103/mm3) | Male | 0.512 ± 0.025 | 0.526 ± 0.027 | 0.114 | 0.306 | 0.116 |
| Female | 0.511 ± 0.024 | 0.446 ± 0.022 | ||||
| Eosinophils (103/mm3) | Male | 0.220 ± 0.025 | 0.196 ± 0.020 | 0.037 | 0.088 | 0.586 |
| Female | 0.187 ± 0.023 | 0.140 ± 0.013 | ||||
| Basophils (103/mm3) | Male | 0.035 ± 0.004 | 0.037 ± 0.004 | 0.721 | 0.855 | 0.775 |
| Female | 0.034 ± 0.004 | 0.034 ± 0.003 | ||||
Mean ± SEM. Statistical analysis: two-way ANOVA, p < 0.05. (S) effect of sex, (E) effect of exercise, and (SxE) interaction between the two factors. (*) significant differences between sexes; (#) significant differences between sedentary and active groups.
Plasma markers of inflammation.
| Sedentary | Active | ANOVA | ||||
|---|---|---|---|---|---|---|
| Sex | Exercise | SxE | ||||
| IL6 (pg/mL) | Male | 3.33 ± 0.27 | 2.55 ± 0.18 | 0.599 | 0.001 | 0.478 |
| Female | 3.39 ± 0.31 | 2.19 ± 0.35 # | ||||
| TNFα (pg/mL) | Male | 26.6 ± 3.0 | 21.5 ± 1.8 | 0.480 | 0.148 | 0.997 |
| Female | 29.1 ± 3.2 | 23.9 ± 5.6 | ||||
| sCD62L (ng/mL) | Male | 1507 ± 61 | 1298 ± 77 | 0.584 | 0.132 | 0.825 |
| Female | 1631 ± 239 | 1351 ± 110 | ||||
| sICAM3 (ng/mL) | Male | 523 ± 24 | 496 ± 18 | 0.549 | 0.318 | 0.832 |
| Female | 531 ± 20 | 514 ± 25 | ||||
| Myeloperoxidase (µkat/mL) | Male | 139 ± 43 | 179 ± 45 | 0.155 | 0.799 | 0.514 |
| Female | 105 ± 36 | 87 ± 29 | ||||
Mean ± SEM. Statistical analysis: two-way ANOVA, p < 0.05. (S) effect of sex, (E) effect of exercise, and (SxE) interaction between the two factors. (#) significant differences between sedentary and active groups.
Figure 1Peripheral blood mononuclear cells gene expression. (A) Interleukin(IL)-1 receptor antagonist, (B) IL-10, (C) IL-1β, (D) NF-κB, (E) TLR4, (F) TNFα, (G) IL-6. Results represent mean ± SEM. Statistical analysis: two-way ANOVA, p < 0.05. (S) effect of sex, (E) effect of exercise, (NS) non-significant. (*) Significant differences between sexes, (#) significant differences between sedentary and active groups.
Figure 2Peripheral blood mononuclear cells protein levels. (A) Tol-like receptor (TLR)2 and (B) TLR4. Results represent mean ± SEM. Statistical analysis: two-way ANOVA, p < 0.05. (E) effect of exercise. (#) Significant differences between sedentary and active groups.